Patent AT-E399554-T1: [Translated] PHARMACEUTICAL COMPOSITION CONTAINING TADALAFIL

Description

Formulations containing a PDE5 inhibitor, a water-soluble diluent, a hydrophilic binder, a disintegrant, and optional microcrystalline cellulose and/or a wetting agent, and their use in treating sexual dysfunction.

Resources

Name Format Description Link
Official Data Source HTML Access the complete Patent AT-E399554-T1: [Translated] PHARMACEUTICAL COMPOSITION CONTAINING TADALAFIL on the official website. Open resource

Tags

Topics

Categories